Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sodium Valproate
Therapeutic Area : Neurology
Study Phase : Phase IV
Recipient : Kathmandu University
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioequivalence Study of Sodium Valproate and Valproic Acid Tablets
Details : Sodium Valproate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Epilepsy.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 08, 2022
Lead Product(s) : Sodium Valproate
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Recipient : Kathmandu University
Deal Size : Inapplicable
Deal Type : Inapplicable